BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29120578)

  • 1. Role of Cannabinoid CB2 Receptor Gene (CNR2) Polymorphism in Children with Immune Thrombocytopenic Purpura in Beni-Suef Governorate in Egypt.
    Ezzat DA; Hammam AA; El-Malah WM; Khattab RA; Mangoud EM
    Egypt J Immunol; 2017 Jan; 24(1):57-66. PubMed ID: 29120578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt.
    Mahmoud Gouda H; Mohamed Kamel NR
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):247-51. PubMed ID: 23406660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura.
    Rossi F; Mancusi S; Bellini G; Roberti D; Punzo F; Vetrella S; Matarese SM; Nobili B; Maione S; Perrotta S
    Haematologica; 2011 Dec; 96(12):1883-5. PubMed ID: 21828121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FcγRIIa and FcγRIIIa genetic polymorphisms in a group of pediatric immune thrombocytopenic purpura in Egypt.
    Eyada TK; Farawela HM; Khorshied MM; Shaheen IA; Selim NM; Khalifa IA
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):64-8. PubMed ID: 22123287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methyltransferase 3B (DNMT3B -579G>T) promotor polymorphism and the susceptibility to pediatric immune thrombocytopenic purpura in Egypt.
    Khorshied MM; El-Ghamrawy MK
    Gene; 2012 Dec; 511(1):34-7. PubMed ID: 23000068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis.
    Ismail M; Khawaja G
    Clin Rheumatol; 2018 Nov; 37(11):2933-2938. PubMed ID: 30032418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential association of tumor necrosis factor-βeta (252 G/A) cytokine gene polymorphism with immune thrombocytopenic purpura among Egyptian children.
    Morgan DS; Afifi RA; El-Hoseiny SM; Amin DG; Ibrahim SYG
    Hematology; 2018 Jun; 23(5):299-303. PubMed ID: 29020887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-α -308G/A gene polymorphism in Egyptian children with immune thrombocytopenic purpura.
    El Sissy MH; El Sissy AH; Elanwary S
    Blood Coagul Fibrinolysis; 2014 Jul; 25(5):458-63. PubMed ID: 24509339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor.
    Minocci D; Massei J; Martino A; Milianti M; Piz L; Di Bello D; Sbrana A; Martinotti E; Rossi AM; Nieri P
    J Affect Disord; 2011 Nov; 134(1-3):427-30. PubMed ID: 21658778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.
    Coppola N; Zampino R; Bellini G; Macera M; Marrone A; Pisaturo M; Boemio A; Nobili B; Pasquale G; Maione S; Adinolfi LE; Perrone L; Sagnelli E; Miraglia Del Giudice E; Rossi F
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):334-40. PubMed ID: 23707465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of IL-17F rs763780 gene polymorphism in immune thrombocytopenia.
    Tolba FM; Diab SM; Abdelrahman AMN; Behairy OG; Almonaem ERA; Mogahed MM; Mohamed SA
    Blood Cells Mol Dis; 2019 Mar; 75():20-25. PubMed ID: 30594845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of interleukin-10 Promoter Polymorphisms to Adult Chronic Immune Thrombocytopenic Purpura in a Cohort of Egyptian Population.
    El Ghannam D; Fawzy IM; Azmy E; Hakim H; Eid I
    Immunol Invest; 2015; 44(7):616-26. PubMed ID: 26436850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of PTPN22 gene polymorphism in childhood immune thrombocytopenic purpura.
    Anis SK; Abdel Ghany EA; Mostafa NO; Ali AA
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):521-5. PubMed ID: 21597364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human platelet antigen 1, 2 and 5 gene polymorphisms in Egyptians and their potential association with susceptibility to immune thrombocytopenic purpura in Egyptian patients.
    Eyada TK; Amin DG; Samih I; Khedr SM
    Hematology; 2018 Mar; 23(2):111-116. PubMed ID: 28823219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-23/Th17 pathway and IL-17A gene polymorphism in Egyptian children with immune thrombocbytopenic purpura.
    Ismail AM; Higazi AM; Nomeir HM; Farag NM
    Ital J Pediatr; 2021 Aug; 47(1):178. PubMed ID: 34446083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Study of Human Killer Cell Immunoglobulin-Like Receptor and Multidrug Resistance Gene Polymorphisms in Children With Immune Thrombocytopenia.
    El-Beblawy NM; Elbarbary NS; Kamal TM; Mahmoud PM
    Clin Appl Thromb Hemost; 2016 Jul; 22(5):429-40. PubMed ID: 25792670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects.
    Yonal O; Eren F; Yılmaz Y; Atuğ Ö; Över HH
    Turk J Gastroenterol; 2014 Dec; 25(6):639-43. PubMed ID: 25599774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNMT3B promoter polymorphism and risk of immune thrombocytopenic purpura in pediatric Egyptians.
    Shaheen IA; Abukhalil RE; Ali DK; Afifi RA
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):636-9. PubMed ID: 22885766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined tumor necrosis factor-α (-308 G/A) and tumor necrosis factor-β (+ 252 A/G) nucleotide polymorphisms and chronicity in Egyptian children with immune thrombocytopenia.
    El-Ghamrawy M; El-Gharbawi N; Shahin G; Abdelhady A; Sayed R; Diaa N; Bishai I
    Int J Hematol; 2023 Jun; 117(6):856-862. PubMed ID: 36802017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention.
    Rossi F; Bellini G; Tolone C; Luongo L; Mancusi S; Papparella A; Sturgeon C; Fasano A; Nobili B; Perrone L; Maione S; del Giudice EM
    Pharmacol Res; 2012 Jul; 66(1):88-94. PubMed ID: 22465144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.